MDPI and ACS Style
Cruz-Nova, P.; Ocampo-GarcÃa, B.; Carrión-Estrada, D.A.; Briseño-Diaz, P.; Ferro-Flores, G.; Jiménez-Mancilla, N.; Correa-Basurto, J.; Bello, M.; Vega-Loyo, L.; Thompson-Bonilla, M.d.R.;
et al. 131I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B–PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer—Biological Characterization, Biokinetics and Dosimetry. Molecules 2022, 27, 5446.
https://doi.org/10.3390/molecules27175446
AMA Style
Cruz-Nova P, Ocampo-GarcÃa B, Carrión-Estrada DA, Briseño-Diaz P, Ferro-Flores G, Jiménez-Mancilla N, Correa-Basurto J, Bello M, Vega-Loyo L, Thompson-Bonilla MdR,
et al. 131I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B–PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer—Biological Characterization, Biokinetics and Dosimetry. Molecules. 2022; 27(17):5446.
https://doi.org/10.3390/molecules27175446
Chicago/Turabian Style
Cruz-Nova, Pedro, Blanca Ocampo-GarcÃa, Dayan Andrea Carrión-Estrada, Paola Briseño-Diaz, Guillermina Ferro-Flores, Nallely Jiménez-Mancilla, José Correa-Basurto, Martiniano Bello, Libia Vega-Loyo, MarÃa del RocÃo Thompson-Bonilla,
and et al. 2022. "131I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B–PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer—Biological Characterization, Biokinetics and Dosimetry" Molecules 27, no. 17: 5446.
https://doi.org/10.3390/molecules27175446
